GENEVA, March 31 -- ASTRAZENECA AB (SE-151 85 Sodertalje) filed a patent application (PCT/EP2024/075763) for "CELL THERAPY" on Sep 16, 2024. With publication no. WO/2025/061607, the details related to the patent application was published on Mar 27, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SJOSTRAND, Karin Jennbacken (AstraZeneca ABSE-151 85 Sodertalje), WANG, Qing-Dong (AstraZeneca ABSE-151 85 Sodertalje), FELLOWS, Mick (AstraZeneca UK Limited1 Francis Crick AvenueCambridge Biomedical CampusCambridge CB2 0AA)
Abstract:
Populations of cells for use in the treatment of heart disease ...